Scientific Research & Development in the US - Market Research Report (2014-2029)

R&D TLC: Returning private investment following previously high interest rates will boost industry growth

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Scientific research and development facilities undertake physical, engineering or life sciences research and development (R&D). Companies that undertake R&D to support their primary operations, like pharmaceutical corporations and government entities, aren't included in this industry. Revenue for the scientific research and development industry increased an annualized 2.3% to $223.7 billion over the past five years. While the COVID-19 pandemic provided increased government funding for many research facilities, dampened private funding in the pandemic and following recovery has been slow to return. In response, industry revenue will decrease 1.7% in 2023.

This industry includes companies and organizations that are involved in physical, engineering or life sciences research and development (R&D). The industry only includes operators whose primary purpose is R&D and excludes players such as pharmaceutical or manufacturing companies that may undertake R&D to support their primary operations. Government entities are also excluded from this industry, though these entities may contract and fund the research this industry undertakes.